IP Library Assignment 052696/0247
Patent Assignment
Reel/Frame 052696/0247

Security Interest

Recorded: 2020-05-19 Pages: 8
Assignor
ADC THERAPEUTICS SA
Executed: 2020-05-19
Assignee
DEERFIELD PARTNERS, L.P., AS GRANTEE
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties (31)
Polynucleotides and Polypeptide Sequences Involved in Cancer
Patent: 8,216,582 →
Application: 12/305,648 →
Publication: US 2010/0086537
Anti-Kidney Associated Antigen 1 (KAAG1) Antibodies
Patent: 9,855,291 →
Application: 13/127,439 →
Publication: US 2011/0223107
Antibodies That Specifically Block the Biological Activity of Kidney Associated Antigen 1 (KAAG1)
Patent: 8,580,257 →
Application: 13/187,424 →
Publication: US 2012/0093819
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Patent: 8,937,163 →
Application: 14/036,204 →
Publication: US 2014/0140990
Pyrrolobenzodiazepine-Antibody Conjugates
Patent: 9,931,414 →
Application: 14/434,816 →
Publication: US 2015/0283262
Pyrrolobenzodiazepine-Antibody Conjugates
Patent: 9,931,415 →
Application: 14/434,823 →
Publication: US 2015/0283263
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Patent: 9,919,056 →
Application: 14/434,826 →
Publication: US 2015/0265722
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Patent: 9,393,302 →
Application: 14/558,186 →
Publication: US 2015/0209427
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Patent: 9,828,426 →
Application: 15/137,368 →
Publication: US 2016/0304605
Pyrrolobenzodiazepine-Antibody Conjugates
Application: 15/529,622 →
Publication: US 2017/0258934
Humanized Anti-Axl Antibodies and Their Conjugates
Application: 15/566,639 →
Publication: US 2018/0127505
Diagnostic Test Involving Anti-CD25-Adc
Application: 15/571,969 →
Publication: US 2018/0142025
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Application: 15/811,545 →
Publication: US 2018/0291099
Antibodies That Specifically Block the Biological Activity of a Tumor Antigen
Application: 15/833,753 →
Publication: US 2018/0369269
Polynucleotides and Polypeptide Sequences Involved in Cancer
Application: 15/863,594 →
Publication: US 2018/0346563
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Application: 15/884,665 →
Publication: US 2018/0169258
Pyrrolobenzodiazepine-Antibody Conjugates
Application: 15/897,835 →
Publication: US 2018/0250417
Pyrrolobenzodiazepine-Antibody Conjugates
Application: 15/911,592 →
Publication: US 2018/0193480
Method for Treating Breast Cancer
Application: 16/164,656 →
Publication: US 2019/0119366
Combination Therapy with an Anti-Axl Antibody-Drug Conjugate
Application: 16/197,891 →
Publication: US 2019/0218291
Pyrrolobenzodiazepine-Antibody Conjugates
Application: 16/484,313 →
Publication: US 2021/0079020
Pyrrolobenzodiazepine-Antibody Conjugates
Application: 16/484,328 →
Publication: US 2021/0093731
Combination Therapy with an Anti-Axl Antibody-Drug Conjugate
Application: 16/605,692 →
Publication: US 2020/0129637
Combination Therapy
Application: 16/605,701 →
Publication: US 2020/0405879
Combination Therapy with an Anti-CD25 Antibody-Drug Conjugate
Application: 16/605,708 →
Publication: US 2022/0016259
Combination Therapy with an Anti-Psma Antibody-Drug Conjugate
Application: 16/605,710 →
Publication: US 2020/0129638
Dosage Regimes for the Administration of an Anti-CD19 Adc
Application: 16/622,649 →
Publication: US 2020/0171164
Dosage Regimes for the Administration of an Anti-CD25 Adc
Application: 16/622,663 →
Publication: US 2020/0405872
Site-Specific Antibody-Drug Conjugates
Application: 16/684,222 →
Publication: US 2020/0399365
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Application: 16/707,482 →
Publication: US 2021/0054067
Pyrrolobenzodiazepine-Antibody Conjugates
Application: 16/806,910 →
Publication: US 2020/0405873
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 18, 2008
From: SOOKNANAN, ROY RABINDRANAUTH; TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 022005/0351 →
Assignment of Assignor's Interest Mar 29, 2012
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 027952/0754 →
Assignment of Assignor's Interest Mar 29, 2012
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 027952/0500 →
Assignment of Assignor's Interest Mar 19, 2013
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 030041/0918 →
Assignment of Assignor's Interest Mar 19, 2013
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 030041/0863 →
Assignment of Assignor's Interest Oct 17, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031425/0017 →
Assignment of Assignor's Interest Oct 31, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031519/0773 →
Assignment of Assignor's Interest Dec 12, 2013
From: TREMBLAY, GILLES BERNARD; MORAITIS, ANNA N.; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031766/0935 →
Assignment of Assignor's Interest Dec 12, 2013
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 031766/0876 →
Assignment of Assignor's Interest Dec 12, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031767/0056 →
Assignment of Assignor's Interest Mar 22, 2016
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 038071/0421 →
Assignment of Assignor's Interest Mar 22, 2016
From: TREMBLAY, GILLES BERNARD; MORAITIS, ANNA N.; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 038071/0075 →
Assignment of Assignor's Interest Mar 22, 2016
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 038071/0204 →
Assignment of Assignor's Interest Sep 20, 2016
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: A.T. DEVELOPMENT SWITZERLAND SÀRL
Reel/Frame 039790/0855 →
Assignment of Assignor's Interest Sep 20, 2016
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 039791/0157 →
Assignment of Assignor's Interest Sep 20, 2016
From: A.T. DEVELOPMENT SWITZERLAND SÀRL
To: ADC THERAPEUTICS S.A.
Reel/Frame 039790/0982 →
Corrective Assignment to Correct the Receiving Party Address Previously Recorded at Reel: 039791 Frame: 0157. Assignor(S) Hereby Confirms the Assignment. Sep 22, 2016
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 040107/0618 →
Assignment of Assignor's Interest Jun 29, 2017
From: TREMBLAY, GILLES BERNARD; MORAITIS, ANNA N.; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 042863/0450 →
Assignment of Assignor's Interest Jun 29, 2017
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 042863/0630 →
Assignment of Assignor's Interest Jun 29, 2017
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 042863/0552 →
Assignment of Assignor's Interest Jun 30, 2017
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 042871/0804 →
Assignment of Assignor's Interest Jun 30, 2017
From: HARTLEY, JOHN; VAN BERKEL, PATRICIUS HENRIKUS CORNELIS
To: ADC THERAPEUTICS SA
Reel/Frame 042871/0669 →
Assignment of Assignor's Interest Jun 30, 2017
From: ALETHIA BIOTHERAPEUTICS INC.
To: ADC THERAPEUTICS SA
Reel/Frame 042880/0186 →
Assignment of Assignor's Interest Dec 20, 2017
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 044450/0769 →
Assignment of Assignor's Interest Dec 20, 2017
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 044450/0793 →